Buying Encycle Gives Zealand Its First External Asset
Zealand Also Gains Access To Encycle’s Peptide Screening Library
Acquiring Encycle Therapeutics brings Zealand Pharma a promising IBD asset and expands the breadth of its peptide discovery platform.
